APA (7th ed.) Citation

JS, W., K, W., JP, N., ME, S., MA, H., AR, D., . . . AJ, N. (2025). Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphoma. Blood cancer journal, 15(1), 120. https://doi.org/10.1038/s41408-025-01326-5

Chicago Style (17th ed.) Citation

JS, Walker, et al. "Integrated Genomics with Refined Cell-of-origin Subtyping Distinguishes Subtype-specific Mechanisms of Treatment Resistance and Relapse in Diffuse Large B-cell Lymphoma." Blood Cancer Journal 15, no. 1 (2025): 120. https://doi.org/10.1038/s41408-025-01326-5.

MLA (9th ed.) Citation

JS, Walker, et al. "Integrated Genomics with Refined Cell-of-origin Subtyping Distinguishes Subtype-specific Mechanisms of Treatment Resistance and Relapse in Diffuse Large B-cell Lymphoma." Blood Cancer Journal, vol. 15, no. 1, 2025, p. 120, https://doi.org/10.1038/s41408-025-01326-5.